| Name | Title | Contact Details |
|---|---|---|
Joseph Barbarite |
Executive Vice President, Global Quality and Compliance | Profile |
Harris Rotman |
Vice President - Head of Regulatory Affairs, Branded Business | Profile |
Brian Gorman |
Vice President and Assistant General Counsel | Profile |
Alexander Nikas |
Vice President and Asst General Counsel Global Commercial Ops and RandD | Profile |
Susan Williamson |
Senior Vice President and Chief Compliance Officer | Profile |
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries.
Reset Therapeutics is a biopharmaceutical company formed to discover, develop and commercialize new therapeutics that modulate the circadian system, the body`s network of internal molecular clocks. The circadian system synchronizes behavioral and physiological processes, including sleep, metabolism, feeding, blood pressure and hormone secretion with the environmental cycles of light, activity and nutrient status. Disruption of normal circadian rhythms is associated with many diseases, including central nervous system, cardiovascular and metabolic disorders, immune system dysfunction and cancer. Novel therapies that reset the body’s biological clocks have the potential to benefit very large and diverse patient populations
Azopharma Contract Pharmaceutical Services is a Miramar, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Dainippon Sumitomo Pharma America Holdings is a Fort Lee, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.